| Keyword | CPC | PCC | Volume | Score | Length of keyword |
|---|---|---|---|---|---|
| pazopanib sales | 1.04 | 0.4 | 4126 | 53 | 15 |
| pazopanib | 0.87 | 0.3 | 3322 | 45 | 9 |
| sales | 1.94 | 0.9 | 2271 | 68 | 5 |
| Keyword | CPC | PCC | Volume | Score |
|---|---|---|---|---|
| pazopanib selleck | 0.17 | 0.7 | 8376 | 35 |
| pazopanib slns | 0.78 | 0.4 | 5053 | 23 |
| pazopanib side effects | 1.99 | 0.1 | 6917 | 52 |
| pazopanib spc | 0.09 | 1 | 9946 | 49 |
| pazopanib sarcoma | 1.6 | 0.9 | 5776 | 62 |
| pazopanib smpc | 0.69 | 0.8 | 2900 | 80 |
| pazopanib swag | 0.33 | 0.5 | 7483 | 15 |
| pazopanib success rate | 1.15 | 0.2 | 2063 | 47 |
| pazopanib structure | 0.06 | 0.2 | 5515 | 85 |
| pazopanib solubility | 1.3 | 1 | 1825 | 20 |
| pazopanib solution | 0.5 | 0.3 | 2643 | 61 |
| pazopanib synthesis | 0.39 | 0.8 | 4482 | 37 |
| pazopanib success stories | 1.64 | 0.1 | 1830 | 29 |
| pazopanib side effects mayo clinic | 0.79 | 0.1 | 3438 | 43 |
| pazopanib nsclc | 1.07 | 0.4 | 8474 | 23 |
| side effects of votrient pazopanib | 1.7 | 0.3 | 1970 | 52 |
